14 ML bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection [Zynrelef]
RxNorm concept 2560308, branded drug (sbd). Prescribable name: ZYNRELEF (BUPivacaine 400 MG / meloxicam 12 MG) in 14 ML Extended Release Solution.
- RxCUI
- 2560308
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2560308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
14 ML BUPivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection [Zynrelef]; Zynrelef (BUPivacaine 400 MG / meloxicam 12 MG) per 14 ML Extended Release Solution; Zynrelef (bupivacaine 400 MG / meloxicam 12 MG) per 14 ML Extended Release Solution
Related concepts
- bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML [Zynrelef] (SBDC, consists of)
- meloxicam 0.88 MG/ML (SCDC, consists of)
- bupivacaine 29.3 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- Zynrelef (BN, has ingredient)
- 14 ML bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
- 47426030102
- 47426030104
- 47426030106
- 47426050102
- 47426050104
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2560308 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2560308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2560308. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.